beta-Estradiol | CAS:50-28-2 | Manufacturer ChemFaces

beta-Estradiol

ChemFaces products have been cited in many studies from excellent and top scientific journals

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $8.9 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Notopterol

Catalog No: CFN98563
CAS No: 88206-46-6
Price: $80/20mg

Peonidin chloride

Catalog No: CFN92034
CAS No: 134-01-0
Price: $380/5mg

Liquiritin apioside

Catalog No: CFN90707
CAS No: 74639-14-8
Price: $90/20mg

Genistein

Catalog No: CFN98681
CAS No: 446-72-0
Price: $30/20mg

Alismoxide

Catalog No: CFN99775
CAS No: 87701-68-6
Price: $258/20mg

Piplartine

Catalog No: CFN96137
CAS No: 20069-09-4
Price: $100/20mg

Ganoderic acid DM

Catalog No: CFN99815
CAS No: 173075-45-1
Price: $318/5mg

Acacetin

Catalog No: CFN98744
CAS No: 480-44-4
Price: $30/20mg

Rebaudioside A

Catalog No: CFN99110
CAS No: 58543-16-1
Price: $40/20mg

Myrrhone

Catalog No: CFN91042
CAS No: 183551-83-9
Price: $388/5mg

Description:

Estradiol, or more precisely, 17β-estradiol, is a human sex hormone and steroid, and the primary female sex hormone. Beta-estradiol has been considered to be a neurotrophic agent, beta-estradiol at a dose of 0.25 microg/day prevents ischemia-induced learning disability and neuronal loss at early stages after transient forebrain ischemia, possibly via a receptor-mediated pathway without attenuating free radical neurotoxicity.

Targets:

LDL

In vitro:

FEBS J. 2015 Jul;282(14):2682-96.

β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.[Pubmed: 25913303]

The lower risk of coronary artery disease in premenopausal women than in men and postmenopausal women implicates sex steroids in cardioprotective processes. beta-Estradiol upregulates liver low-density lipoprotein receptor (LDLR), which, in turn, decreases circulating levels of low-density lipoprotein, which is a risk factor for coronary artery disease. Conversely, LDLR protein is negatively regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9).
METHODS AND RESULTS:
Herein, we investigated PCSK9 regulation by beta-Estradiol and its impact on LDLR in human hepatocarcinoma HuH7 cells grown in the presence or absence of β-estradiol. Immunoblot analysis showed upregulation of LDLR at 3 μm beta-Estradiol (140%), and the upregulation reached 220% at 10 μm beta-Estradiol; only at the latter dose was an increase in LDLR mRNA detected by qPCR, suggesting post-translational regulation of LDLR. No changes in PCSK9 mRNA or secreted protein levels were detected by qPCR or ELISA, respectively. beta-Estradiol-conditioned medium devoid of PCSK9 failed to upregulate LDLR. Similarly, PCSK9 knockdown cells showed no upregulation of LDLR by beta-Estradiol. Together, these results indicate a requirement for PCSK9 in the beta-Estradiol-induced upregulation of LDLR. A radiolabeling assay showed a significant, dose-dependent decrease in the ratio of secreted phosphoPCSK9 to total secreted PCSK9 with increasing beta-Estradiol levels, suggesting a change in the functional state of PCSK9 in the presence of beta-Estradiol.
CONCLUSIONS:
Our results indicate that the protein upregulation of LDLR at subtranscriptionally effective doses of beta-Estradiol, and its supratranscriptional upregulation at 10 μm beta-Estradiol, occur through an extracellular PCSK9-dependent mechanism.

In vivo:

Epilepsy Res. 2013 Dec;107(3):297-301.

Gonadal status-dependent effects of in vivo β-estradiol administration to female rats on in vitro epileptiform activity induced by low [Mg2+]₀ in combined hippocampus-entorhinal cortex slices.[Pubmed: 24113171]

There are controversial data regarding estrogen effects on neuronal excitability.
METHODS AND RESULTS:
We investigated whether beta-Estradiol (EB) administration to ovariectomized (OVX) or gonadally intact female rats alters epileptiform activity within the dentate gyrus network induced in vitro by removing [Mg2+]o in combined hippocampus-entorhinal cortex slices. In vivo beta-Estradiol administration significantly influenced the epileptiform activity in gonadal status-dependent manner. The onset of epileptiform discharges was modestly delayed in slices from OVX rats replaced with physiologically relevant doses of beta-Estradiol but the number of discharges was not affected. In contrast, beta-Estradiol administration to gonadally intact rats had robust effects such that: beta-Estradiol delayed the onset of discharges but significantly increased their number within the dentate gyrus network.
CONCLUSIONS:
Our data suggest that beta-Estradiol in physiologically relevant concentrations does not seem to negatively affect hippocampal neuronal excitability, nevertheless supraphysiological beta-Estradiol levels may enhance seizure severity.

beta-Estradiol Description

Source:
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Animal Research:

Neurosci Res. 1997 Dec;29(4):345-54.

Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil.[Pubmed: 9527626]

beta-Estradiol has been considered to be a neurotrophic agent, but its in vivo effect on gerbils with transient forebrain ischemia has not yet been demonstrated.
METHODS AND RESULTS:
In the first set of the present experiments, we infused beta-Estradiol at a dose of 0.05 or 0.25 microg/day for 7 days into the lateral ventricles of normothermic gerbils starting 2 h before 3-min forebrain ischemia. beta-Estradiol infusion at a dose of 0.25 microg/day prevented significantly the ischemia-induced reduction of response latency time as revealed by a step-down passive avoidance task. Subsequent light and electron microscopic examinations showed that pyramidal neurons in the hippocampal CA1 region as well as synapses within the strata moleculare, radiatum and oriens of the region were significantly more numerous in gerbils infused with beta-Estradiol than in those receiving saline infusion. beta-Estradiol at a dose of 1.25 microg/day was ineffective and occasionally increased the mortality of experimental animals. Since the total brain content of exogenous beta-Estradiol at 12 h after forebrain ischemia was estimated to be less than 145 ng, the second set of experiments focused on the neurotrophic action of beta-Estradiol at concentrations around 100 ng/ml in vitro. beta-Estradiol at concentrations of 1-100 ng/ml facilitated the survival and process extension of cultured hippocampal neurons, but it did not exhibit any significant radical-scavenging effects at the concentration range. On the other hand, 100 microg/ml of beta-Estradiol, even though failing to support hippocampal neurons in vitro, effectively scavenged free radicals in subsequent in vitro studies, as demonstrated elsewhere.
CONCLUSIONS:
These findings suggest that beta-Estradiol at a dose of 0.25 microg/day prevents ischemia-induced learning disability and neuronal loss at early stages after transient forebrain ischemia, possibly via a receptor-mediated pathway without attenuating free radical neurotoxicity.

Product Name	beta-Estradiol
Price:	$40 / 20mg
CAS No.:	50-28-2
Catalog No.:	CFN90035
Molecular Formula:	C₁₈H₂₄O₂
Molecular Weight:	272.38 g/mol
Purity:	>=98%
Type of Compound:	Steroids
Physical Desc.:	Powder
Source:
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download:	COA MSDS SDF
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Neuroprotection Compound Library Steroids Compound Library LDL Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	3.6713 mL	18.3567 mL	36.7134 mL	73.4268 mL	91.7835 mL
5 mM	0.7343 mL	3.6713 mL	7.3427 mL	14.6854 mL	18.3567 mL
10 mM	0.3671 mL	1.8357 mL	3.6713 mL	7.3427 mL	9.1784 mL
50 mM	0.0734 mL	0.3671 mL	0.7343 mL	1.4685 mL	1.8357 mL
100 mM	0.0367 mL	0.1836 mL	0.3671 mL	0.7343 mL	0.9178 mL

CFN90840	Rubrosterone	19466-41-2	334.4	C₁₉H₂₆O₅
CFN90043	Dehydroepiandrosterone	53-43-0	288.42	C₁₉H₂₈O₂
CFN90034	Testosterone	58-22-0	288.42	C₁₉H₂₈O₂
CFN90035	beta-Estradiol	50-28-2	272.38	C₁₈H₂₄O₂
CFN96786	17alpha-Estradiol	57-91-0	272.38	C₁₈H₂₄O₂
CFN90042	Estrone	53-16-7	270.37	C₁₈H₂₂O₂
CFN93007	Guggulsterone E&Z	95975-55-6	312.5	C₂₁H₂₈O₂